Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus reuteri and Reduced Plaque Index

Research synthesisLow evidenceMixed effect size4 studies · 3 beneficial · 1 neutral · 0 harmful

Across 4 studies, 3 reported beneficial effects on plaque index, but the highest-quality RCT (evidence score 5) found no effect. The predominant effect size among beneficial studies was mixed (small to large). Evidence is limited by small sample sizes, inconsistent findings, and poorly reported doses.

Caveats: Evidence base is small (only 4 studies) — conclusions should be considered preliminary. The highest-quality study (RCT with evidence score 5) showed no significant effect, while lower-quality studies reported benefits. Effects may be population-specific (e.g., peri-implantitis, adolescents with betel quid chewing) and not generalizable. Doses were poorly reported, limiting dose-response assessment.

Generated Jul 9, 2026
Doses used in studies
  • day: 2 (median 2, IQR 22) 1 study
  • lozenge/day: 1 (median 1, IQR 11) 1 study
Time to effect
Median: 4.5 months · IQR 3.8 months5.3 months · Range 3 months6 months — Reported in 2 of 4 studies
4 of 4 papers
Back to top